Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
AGN
Allergan plc
AGN
|
+$603M |
| 3 |
Meta Platforms (Facebook)
META
|
+$459M |
| 4 |
Alibaba
BABA
|
+$361M |
| 5 |
Amazon
AMZN
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$2.49B |
| 2 |
Qualcomm
QCOM
|
+$424M |
| 3 |
Oracle
ORCL
|
+$369M |
| 4 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$351M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.16% |
| 2 | Financials | 5.29% |
| 3 | Healthcare | 5.26% |
| 4 | Consumer Discretionary | 4.52% |
| 5 | Communication Services | 3.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Kulicke & Soffa
KLIC
$4.67B
| $2.14M | ﹤0.01% |
91,130
+15,095
| +20% | +$332K |
|
2752
Atara Biotherapeutics
ATRA
$75.5M
| $2.14M | ﹤0.01% |
6,057
+3,285
| +119% | +$1.23M |
|
2753
CALL
Helmerich & Payne
HP
$3.45B
| $2.14M | ﹤0.01% |
53,300
+16,200
| +44% | +$715K |
|
2754
Dine Brands
DIN
$456M
| $2.13M | ﹤0.01% |
28,107
+2,173
| +8% | +$178K |
|
2755
CALL
FMC
FMC
$1.34B
| $2.13M | ﹤0.01% |
24,300
-1,300
| -5% | -$112K |
|
2756
CALL
Lumen
LUMN
$6.57B
| $2.13M | ﹤0.01% |
170,500
-58,600
| -26% | -$696K |
|
2757
PUT
Aptiv
APTV
$12B
| $2.12M | ﹤0.01% |
24,300
+12,400
| +104% | +$1.04M |
|
2758
Central Garden & Pet Co Class A
CENTA
$2.37B
| $2.12M | ﹤0.01% |
95,765
+57,240
| +149% | +$1.14M |
|
|
RAD
2759
CALL
DELISTED
Rite Aid Corporation
RAD
| $2.12M | ﹤0.01% |
305,360
+55,945
| +22% | +$402K |
|
2760
CALL
Itaú Unibanco
ITUB
$93.2B
| $2.12M | ﹤0.01% |
346,537
+56,210
| +19% | +$365K |
|
2761
Beyond Meat
BYND
$292M
| $2.12M | ﹤0.01% |
14,233
-3,714
| -21% | -$612K |
|
2762
PUT
Xerox
XRX
$386M
| $2.12M | ﹤0.01% |
70,700
-2,700
| -4% | -$84.6K |
|
|
XLRN
2763
DELISTED
Acceleron Pharma
XLRN
| $2.12M | ﹤0.01% |
53,520
-19,510
| -27% | -$846K |
|
|
CLGX
2764
DELISTED
Corelogic, Inc.
CLGX
| $2.12M | ﹤0.01% |
45,692
+12,338
| +37% | +$567K |
|
2765
AXIS Capital
AXS
$7.68B
| $2.1M | ﹤0.01% |
31,540
-24,971
| -44% | -$1.58M |
|
2766
PUT
Bilibili
BILI
$7.99B
| $2.1M | ﹤0.01% |
148,900
+64,300
| +76% | +$966K |
|
2767
CALL
First Majestic Silver
AG
$7.41B
| $2.1M | ﹤0.01% |
230,900
+70,000
| +44% | +$684K |
|
2768
First Trust Preferred Securities and Income ETF
FPE
$6.32B
| $2.1M | ﹤0.01% |
106,468
+47,230
| +80% | +$926K |
|
2769
CVB Financial
CVBF
$3.94B
| $2.1M | ﹤0.01% |
100,651
+59,436
| +144% | +$1.24M |
|
2770
Silgan Holdings
SLGN
$4.23B
| $2.1M | ﹤0.01% |
69,933
+35,004
| +100% | +$1.06M |
|
2771
CALL
Interactive Brokers
IBKR
$39.2B
| $2.1M | ﹤0.01% |
156,000
-3,200
| -2% | -$39.8K |
|
2772
Insmed
INSM
$21.4B
| $2.1M | ﹤0.01% |
118,880
-50,336
| -30% | -$972K |
|
2773
Donaldson
DCI
$10.9B
| $2.1M | ﹤0.01% |
40,252
+6,977
| +21% | +$345K |
|
2774
CALL
Idexx Laboratories
IDXX
$44.1B
| $2.09M | ﹤0.01% |
7,700
+3,000
| +64% | +$835K |
|
2775
Commault Systems
CVLT
$4.88B
| $2.09M | ﹤0.01% |
46,820
+4,202
| +10% | +$192K |
|
Similar funds
Citigroup's Q3 2019 Portfolio in Review
As of Q3 2019, Citigroup held 8,008 positions worth $126B, up 1.9% from $124B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup's Q3 2019 filing shows 182 new, 3,096 increased, 3,760 reduced and 268 closed positions. Its largest new stake was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.49B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.8% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q3 2019 buy was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.26B increase.
- Citigroup's biggest Q3 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.49B.
- Citigroup fully exited Red Hat Inc in Q3 2019, selling an estimated $311M.
- Citigroup's ten largest holdings make up 21% of its $126B portfolio in Q3 2019.
- Citigroup opened 182 new positions and closed 268 in Q3 2019.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $126B.
Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.